Hospital Acquired Pneumonia Clinical Trial
Official title:
Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype, an International Phase III, Double-blind, Placebo-controlled, Randomized Trial
Determine the efficacy of dexamethasone plus standard of care (SOC) as compared to placebo plus SOC for treating severe hospital-acquired pneumonia in critically ill patients with a proinflammatory phenotype; It's an international phase III, double-blind, placebo-controlled, randomized trial.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03348579 -
Hospital-acquired Pneumonia in Intensive Care Unit
|
||
| Completed |
NCT02454114 -
HOME FIRST Pilot: a Study of Early Supported Discharge in Patients With Lower Respiratory Tract Infections
|
N/A | |
| Recruiting |
NCT05487586 -
Real-World Study of Ceftazidime Avibactam in China
|
||
| Completed |
NCT01577862 -
Colistin and Rifampicin for MDR-Acinetobacter
|
Phase 3 | |
| Completed |
NCT03039998 -
Validity of Biological Material Sampling in Patients With Hospital-acquired Pneumonia
|
N/A | |
| Completed |
NCT01883869 -
Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor
|
Phase 1 | |
| Recruiting |
NCT02203110 -
The Impact of Simultaneous Presence of Viral and Bacterial Pathogens on Therapy and Course of Severe Pneumonia
|
N/A | |
| Completed |
NCT01769742 -
Early Mobility Bundle to Prevent Hospital Acquired Pneumonia (HAP) in Medical Inpatients
|
N/A | |
| Completed |
NCT04882085 -
Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults
|
Phase 4 | |
| Completed |
NCT02058004 -
Does Cricoid Pressure Reduce the Risk of Aspiration?
|
N/A |